All Stories

  1. Stage III uterine serous carcinoma: modern trends in multimodality treatment

    Article • Journal of Gynecologic Oncology, January 2020, Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy (KAMJE)

    Gloria Huang

  2. Precision Therapy for Aggressive Endometrial Cancer by Reactivation of Protein Phosphatase 2A

    Article • Cancer Research, August 2019, American Association for Cancer Research (AACR)

    Gloria Huang

  3. Neutrophil count predicts mortality in women with aggressive uterine cancer.

    Article • International Journal of Gynecological Cancer, July 2019, BMJ

    Gloria Huang

  4. Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer

    Article • Journal of Clinical Oncology, May 2018, American Society of Clinical Oncology (ASCO)

    Gloria Huang

  5. IGF2 is a prognostic biomarker in aggressive uterine cancer

    Article • Cancer Medicine, February 2018, Wiley

    Gloria Huang

  6. Genetics of Clear Cell Endometrial Cancer

    Article • Cancer, May 2017, Wiley

    Gloria Huang

  7. Retreatment with aromatase inhibitor therapy in the management of granulosa cell tumor

    Article • Gynecologic Oncology Reports, January 2016, Elsevier

    Gloria Huang

  8. Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds

    Article • Seminars in Cancer Biology, December 2015, Elsevier

    Professor Nicol Keith, Gloria Huang

  9. IGF2 signaling and regulation in cancer

    Article • Cytokine & Growth Factor Reviews, June 2015, Elsevier

    Gloria Huang

  10. The impact of obesity on prostate cancer recurrence observed after exclusion of diabetics

    Article • Cancer Causes & Control, March 2015, Springer Science + Business Media

    Gloria Huang

  11. Transforming Growth Factor β1 and Extracellular Matrix Protease Expression in the Uterosacral Ligaments of Patients With and Without Pelvic Organ Prolapse

    Article • Female Pelvic Medicine & Reconstructive Surgery, January 2015, Wolters Kluwer Health

    Gloria Huang

  12. Insulin-Like Growth Factor 2 Silencing Restores Taxol Sensitivity in Drug Resistant Ovarian Cancer

    Article • PLoS ONE, June 2014, PLOS

    Gloria Huang

  13. Phase II trial of adjuvant pelvic radiation “sandwiched” between combination paclitaxel and carboplatin in women with uterine papillary serous carcinoma

    Article • Gynecologic Oncology, January 2012, Elsevier

    Gloria Huang

  14. Phase II trial of adjuvant pelvic radiation “sandwiched” between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcoma

    Article • Gynecologic Oncology, January 2012, Elsevier

    Gloria Huang

  15. Clinical utility of chromogranin a and octreotide in large cell neuro endocrine carcinoma of the uterine corpus

    Article • Rare Tumors, November 2011, SAGE Publications

    Gloria Huang

  16. Downregulation of Filamin A Interacting Protein 1-Like is Associated with Promoter Methylation and Induces an Invasive Phenotype in Ovarian Cancer

    Article • Molecular Cancer Research, June 2011, American Association for Cancer Research (AACR)

    Dr Stephen M Hewitt, Gloria Huang

  17. Performance of Serum CA125 as a Prognostic Biomarker in Patients With Uterine Papillary Serous Carcinoma

    Article • International Journal of Gynecological Cancer, April 2011, Wolters Kluwer Health

    Gloria Huang

  18. Co-expression of GPR30 and ERβ and their association with disease progression in uterine carcinosarcoma

    Article • American Journal of Obstetrics and Gynecology, September 2010, Elsevier

    Gloria Huang

  19. Insulin-like Growth Factor 2 Expression Modulates Taxol Resistance and Is a Candidate Biomarker for Reduced Disease-Free Survival in Ovarian Cancer

    Article • Clinical Cancer Research, April 2010, American Association for Cancer Research (AACR)

    Gloria Huang

  20. Extragenital adenosarcoma: A case report, review of the literature, and management discussion

    Article • Gynecologic Oncology, December 2009, Elsevier

    Gloria Huang

  21. A phase II study of weekly topotecan and docetaxel in heavily treated patients with recurrent uterine and ovarian cancers

    Article • Gynecologic Oncology, June 2009, Elsevier

    Gloria Huang

  22. Tissue microarray analysis of hormonal signaling pathways in uterine carcinosarcoma

    Article • American Journal of Obstetrics and Gynecology, April 2009, Elsevier

    Gloria Huang

  23. Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma

    Article • Gynecologic Oncology, December 2007, Elsevier

    Gloria Huang

  24. Accuracy of preoperative endometrial sampling for the detection of high-grade endometrial tumors

    Article • American Journal of Obstetrics and Gynecology, March 2007, Elsevier

    Gloria Huang

  25. Survival and toxicity differences between 5-day and weekly cisplatin in patients with locally advanced cervical cancer

    Article • Cancer, January 2007, Wiley

    Gloria Huang

  26. Potentiation of Taxol Efficacy by Discodermolide in Ovarian Carcinoma Xenograft-Bearing Mice

    Article • Clinical Cancer Research, January 2006, American Association for Cancer Research (AACR)

    Gloria Huang

  27. Consolidation therapy for ovarian cancer

    Article • The Women s Oncology Review, March 2005, Taylor & Francis

    Gloria Huang

  28. Total laparoscopic hysterectomy for oncological indications with outcomes stratified by age

    Article • Gynecologic Oncology, October 2004, Elsevier

    Gloria Huang

  29. Selective incorporation of total laparoscopic hysterectomy for adnexal pathology and body mass index

    Article • Gynecologic Oncology, April 2004, Elsevier

    Gloria Huang

  30. Total laparoscopic hysterectomy: body mass index and outcomes

    Article • Obstetrics and Gynecology, December 2003, Wolters Kluwer Health

    Gloria Huang

  31. Liposomal Doxorubicin for Treatment of Metastatic Chemorefractory Vulvar Adenocarcinoma

    Article • Gynecologic Oncology, December 2002, Elsevier

    Gloria Huang